Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Comment by stanleyon Feb 15, 2012 4:07pm

187 Views

Post# 19539423

RE:Interesting ..Closeology & Victory Mines

Terry:

[S] I hate to point out the gems of your resident Yahoo genius; but how else can I get through the day with his/her oxymoronic logic:

"I stopped monitoring Brigus's exploration results and really can't speak toward the company itself or it's prospects, but I can tell you that BF shows no indication of being the world class gold mine that Russell claimed it would be"

[S] How can one discuss BRD's upside without a study of BRD's phenomenal exploration results. Randy Abrahamson's comments along with BNN commentary suggests that recent valuations of juniors put them into the way oversold category.

Cheers

Stanley

Bullboard Posts

Who, why, and what of the great "Crypto Surge"